153 related articles for article (PubMed ID: 10265094)
1. FDA approval of comparative claims for prescription drugs--the Moxam case.
Marcus D
Drug Inf J; 1983; 17(3):171-5. PubMed ID: 10265094
[TBL] [Abstract][Full Text] [Related]
2. Introduction to the new prescription drug labeling by the Food and Drug Administration.
Lal R; Kremzner M
Am J Health Syst Pharm; 2007 Dec; 64(23):2488-94. PubMed ID: 18029957
[TBL] [Abstract][Full Text] [Related]
3. To inform or persuade? Direct-to-consumer advertising of prescription drugs.
Berndt ER
N Engl J Med; 2005 Jan; 352(4):325-8. PubMed ID: 15673797
[No Abstract] [Full Text] [Related]
4. The regulation of patient-reported outcome claims: need for a flexible standard.
Morris LA; Miller DW
Value Health; 2002; 5(4):372-81. PubMed ID: 12102699
[TBL] [Abstract][Full Text] [Related]
5. Prescription drug products; patient package insert requirements--Food and Drug Administration. Final rule.
Fed Regist; 1981 Jan; 46(1):28-30. PubMed ID: 10324121
[TBL] [Abstract][Full Text] [Related]
6. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
Rossen BR
Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
[TBL] [Abstract][Full Text] [Related]
7. The federal regulation of prescription drug advertising and promotion.
Kessler DA; Pines WL
JAMA; 1990 Nov; 264(18):2409-15. PubMed ID: 2231998
[TBL] [Abstract][Full Text] [Related]
8. Food and Drug Administration--Prescription drug products; patient package inserts requirements. Final rule.
Fed Regist; 1980 Sep; 45(179 Pt 2):60754-84. PubMed ID: 10248285
[TBL] [Abstract][Full Text] [Related]
9. How the FDA and the ADA affect development of prescription drugs for oral care.
Cooley WE
J Public Health Dent; 1992; 52(6):350-2. PubMed ID: 1432922
[TBL] [Abstract][Full Text] [Related]
10. Evaluating promotional claims as false or misleading.
Brushwood DB; Knox CA; Liu W; Jenkins KA
Am J Health Syst Pharm; 2013 Nov; 70(21):1941-4. PubMed ID: 24128969
[TBL] [Abstract][Full Text] [Related]
11. Examining the FDA's oversight of direct-to-consumer advertising.
Gahart MT; Duhamel LM; Dievler A; Price R
Health Aff (Millwood); 2003; Suppl Web Exclusives():W3-120-3. PubMed ID: 14527243
[TBL] [Abstract][Full Text] [Related]
12. Regulation of prescription drug promotion: direct-to-consumer advertising.
Baylor-Henry M; Drezin NA
Clin Ther; 1998; 20 Suppl C():C86-95. PubMed ID: 9915094
[TBL] [Abstract][Full Text] [Related]
13. The Conundrum of Online Prescription Drug Promotion Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".
Wanasika I
Int J Health Policy Manag; 2016 Mar; 5(6):391-2. PubMed ID: 27285519
[TBL] [Abstract][Full Text] [Related]
14. The impact of Wyeth v. Levine on FDA regulation of prescription drugs.
Ausness RC
Food Drug Law J; 2010; 65(2):247-83, i-ii. PubMed ID: 24475542
[TBL] [Abstract][Full Text] [Related]
15. Prescription drug products; patient labeling requirements: proposed rule.
Fed Regist; 1979 Jul; 44(131 Pt 2):40015-41. PubMed ID: 10242793
[No Abstract] [Full Text] [Related]
16. The FDA Export Reform and Enhancement Act of 1996: the FDA's new extraterritorial authority over labeling and promotional practices.
Helmanis AM
Food Drug Law J; 1996; 51(4):631-5. PubMed ID: 11797732
[No Abstract] [Full Text] [Related]
17. Prescription drug product labeling; medication guide requirements--FDA. Final rule.
Fed Regist; 1998 Dec; 63(230):66378-400. PubMed ID: 10338877
[TBL] [Abstract][Full Text] [Related]
18. Origins of the prohibition against off-label promotion.
Coleman TS
Food Drug Law J; 2014; 69(2):161-236, i. PubMed ID: 25163210
[TBL] [Abstract][Full Text] [Related]
19. The FDA, contraceptive marketing approval and products liability litigation: Depo-Provera and the risk of osteoporosis.
Green W
Food Drug Law J; 2013; 68(2):115-35, i. PubMed ID: 24640465
[TBL] [Abstract][Full Text] [Related]
20. Tort reform by regulation: FDA prescription drug labeling rules and preemption of state tort claims.
Moreland MP
J Health Life Sci Law; 2007; 1(1):39, 41-62. PubMed ID: 18610730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
